Cargando…
Artemisinin-Naphthoquine Combination (ARCO(®)): An Overview of the Progress
With the rapidly spreading resistance of Plasmodium falciparum to available non-artemisinin antimalarial drugs, new and novel pharmaceuticals are needed. ARCO(®) is a new generation ACT, one of several artemisinin-based combinations developed in China to counter antimalarial drug resistance. ARCO(®)...
Autores principales: | Hombhanje, Francis W., Huang, Qingyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034067/ http://dx.doi.org/10.3390/ph3123581 |
Ejemplares similares
-
Artemisinin-naphthoquine combination (ARCO™) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: A preliminary report on safety and efficacy
por: Hombhanje, Francis W, et al.
Publicado: (2009) -
Artemisinin‐naphthoquine for treating uncomplicated Plasmodium falciparum malaria
por: Isba, Rachel, et al.
Publicado: (2015) -
Population Pharmacokinetics of Antimalarial Naphthoquine in Combination with Artemisinin in Tanzanian Children and Adults: Dose Optimization
por: Ali, Ali Mohamed, et al.
Publicado: (2022) -
A systematic review of the efficacy of a single dose artemisinin–naphthoquine in treating uncomplicated malaria
por: Naing, Cho, et al.
Publicado: (2015) -
Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
por: Moore, Brioni R., et al.
Publicado: (2017)